← Leaderboards
Jeffrey David Klausner
University Of Southern California
$10,764,010
Attributed
$14,860,621
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,860,621 · 10
By mechanism
R01$12,307,854 · 3
R21$2,306,689 · 6
D43$246,078 · 1
Top collaborators
- Andrew Medina-Marino8 shared
- Carlos F. Caceres5 shared
- Giang M Le2 shared
- Chelsea Morroni2 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionResponseIncidenceHiv InfectionsEnrollmentSyphilisAftercareSexually Transmitted DiseasesFollow-UpParticipantMolecularNeisseria GonorrhoeaeFrequenciesTreatment FailureAntibioticsPregnancySpecimenProgramsBacteriaCharacteristicsScreeningCephalosporinsCostRecruit
Grant awards (33)
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis$702,115
R01 · FY2025 · AI · contact PI
Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design$433,667
R01 · FY2025 · AI · contact PI
V-STAR - Vietnam Research Training Program on Sexually Transmitted Diseases and Antimicrobial Resistance$246,078
D43 · FY2025 · TW · contact PI
Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design$240,624
R01 · FY2025 · AI · contact PI
Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design$706,759
R01 · FY2024 · AI · contact PI
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes$651,599
R01 · FY2024 · AI · contact PI
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis$616,766
R01 · FY2024 · AI · contact PI
Pilot study of linezolid for early syphilis treatment$150,436
R21 · FY2024 · AI · contact PI
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes$959,255
R01 · FY2023 · AI · contact PI
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis$610,003
R01 · FY2023 · AI · contact PI
Pilot study of linezolid for early syphilis treatment$237,175
R21 · FY2023 · AI · contact PI
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes$951,169
R01 · FY2022 · AI · contact PI
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis$610,027
R01 · FY2022 · AI · contact PI
Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam$161,872
R21 · FY2022 · AI · contact PI
Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes$963,145
R01 · FY2021 · AI · contact PI
Clinical Trial Comparing the Effectiveness of Cefixime Versus Penicillin G for Treatment of Early Syphilis$665,080
R01 · FY2021 · AI · contact PI
Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design$624,293
R01 · FY2021 · AI · contact PI
Evaluating STI screening and antimicrobial resistance in Neisseria gonorrhoeae among PrEP users in Vietnam$220,833
R21 · FY2021 · AI · contact PI
The diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences$195,558
R21 · FY2021 · HD · contact PI
Clinical study of STI screening to prevent adverse birth and newborn outcomes$6,421
R01 · FY2021 · AI · contact PI
Clinical study of STI screening to prevent adverse birth and newborn outcomes$811,925
R01 · FY2020 · AI · contact PI
Clinical trial comparing the effectiveness of cefixime versus penicillin G for treatment of early syphilis$662,921
R01 · FY2020 · AI · contact PI
Syphilis Immunology and Biology to Improve Clinical Management and Vaccine Design$484,467
R01 · FY2020 · AI · contact PI
Syphilis immunology and biology to improve clinical management and vaccine design$307,081
R01 · FY2020 · AI · contact PI
The diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences$202,822
R21 · FY2020 · HD · contact PI
Syphilis immunology and biology to improve clinical management and vaccine design$634,347
R01 · FY2019 · AI · contact PI
Syphilis immunology and biology to improve clinical management and vaccine design$666,190
R01 · FY2018 · AI · contact PI
Reducing excess broad-spectrum antibiotic use in gonorrhea$231,000
R21 · FY2017 · AI · contact PI
Reducing excess broad-spectrum antibiotic use in gonorrhea$192,500
R21 · FY2016 · AI · contact PI
Pilot Study of STI Screening and Treatment for PMTCT$182,186
R21 · FY2016 · HD · contact PI
Controlling Drug Resistant Gonorrhea with Real-Time PCR Susceptibility Testing$195,050
R21 · FY2015 · AI · contact PI
Pilot Study of STI Screening and Treatment for PMTCT$170,060
R21 · FY2015 · HD · contact PI
Controlling Drug Resistant Gonorrhea with Real-Time PCR Susceptibility Testing$167,197
R21 · FY2014 · AI · contact PI